Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with MYD88 L265P mutation

Ivan Dlouhy; Marc Antoni Armengol; Clara Recasens-Zorzo; Marcelo L. Ribeiro; Patricia Pérez-Galán; Francesc Xavier Bosch José; Armando López Guillermo; Gaël Roué

doi:10.3324/haematol.2020.278258

Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with MYD88 L265P mutation

Ivan Dlouhy, Marc Antoni Armengol, Clara Recasens-Zorzo, Marcelo L. Ribeiro, Patricia Pérez-Galán, Francesc Xavier Bosch José, Armando López Guillermo, Gaël Roué

Departament de Medicina

Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)

Producció científica: Contribució a revista › Article › Recerca › Avaluat per experts

2 Cites (Scopus)

Idioma original	Anglès
Pàgines (de-a)	2749-2753
Nombre de pàgines	5
Revista	Haematologica
Volum	106
Número	10
DOIs	https://doi.org/10.3324/haematol.2020.278258
Estat de la publicació	Publicada - 2021

Accés al document

10.3324/haematol.2020.278258

https://ddd.uab.cat/record/250423

Altres arxius i enllaços

https://www.scopus.com/pages/publications/85116210506

Com citar-ho

Dlouhy, I., Armengol, M. A., Recasens-Zorzo, C., Ribeiro, M. L., Pérez-Galán, P., Bosch José, F. X., López Guillermo, A., & Roué, G. (2021). Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with MYD88 L265P mutation. Haematologica, 106(10), 2749-2753. https://doi.org/10.3324/haematol.2020.278258

Dlouhy, Ivan ; Armengol, Marc Antoni ; Recasens-Zorzo, Clara et al. / Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with MYD88 L265P mutation. In: Haematologica. 2021 ; Vol. 106, Núm. 10. pàg. 2749-2753.

@article{27a92bdd9ea7407aad7bcc68ac6a5e22,

title = "Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with MYD88 L265P mutation",

author = "Ivan Dlouhy and Armengol, \{Marc Antoni\} and Clara Recasens-Zorzo and Ribeiro, \{Marcelo L.\} and Patricia P{\'e}rez-Gal{\'a}n and \{Bosch Jos{\'e}\}, \{Francesc Xavier\} and \{L{\'o}pez Guillermo\}, Armando and Ga{\"e}l Rou{\'e}",

year = "2021",

doi = "10.3324/haematol.2020.278258",

language = "English",

volume = "106",

pages = "2749--2753",

number = "10",

}

Dlouhy, I, Armengol, MA, Recasens-Zorzo, C, Ribeiro, ML, Pérez-Galán, P, Bosch José, FX, López Guillermo, A & Roué, G 2021, 'Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with MYD88 L265P mutation', Haematologica, vol. 106, núm. 10, pàg. 2749-2753. https://doi.org/10.3324/haematol.2020.278258

Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with MYD88 L265P mutation. / Dlouhy, Ivan; Armengol, Marc Antoni; Recasens-Zorzo, Clara et al.
In: Haematologica, Vol. 106, Núm. 10, 2021, pàg. 2749-2753.

Producció científica: Contribució a revista › Article › Recerca › Avaluat per experts

TY - JOUR

T1 - Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with MYD88 L265P mutation

AU - Dlouhy, Ivan

AU - Armengol, Marc Antoni

AU - Recasens-Zorzo, Clara

AU - Ribeiro, Marcelo L.

AU - Pérez-Galán, Patricia

AU - Bosch José, Francesc Xavier

AU - López Guillermo, Armando

AU - Roué, Gaël

PY - 2021

Y1 - 2021

UR - https://www.scopus.com/pages/publications/85116210506

U2 - 10.3324/haematol.2020.278258

DO - 10.3324/haematol.2020.278258

M3 - Article

C2 - 33979991

SN - 0390-6078

VL - 106

SP - 2749

EP - 2753

JO - Haematologica

JF - Haematologica

IS - 10

ER -

Dlouhy I, Armengol MA, Recasens-Zorzo C, Ribeiro ML, Pérez-Galán P, Bosch José FX et al. Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with MYD88 L265P mutation. Haematologica. 2021;106(10):2749-2753. doi: 10.3324/haematol.2020.278258